- Filed
- Aug 8, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 3, 2024 | 82.95M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 82.85M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 80.68M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$10.99M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$14.06M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $109.85M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $109.8M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $640K |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $640K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $58.22M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $75.64M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | $154.3M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | $169.73M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | $205.07M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | $142.61M |
| Current Liabilities restated | Q1 2024 · Mar 31, 2024 | $58M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $51.24M |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $170.07M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $162.96M |
| Current Assets restated | Q1 2024 · Mar 31, 2024 | $197.15M |
| Current Assets restated | Q1 2024 · Dec 31, 2023 | $207.8M |
| Total Assets restated | Q1 2024 · Mar 31, 2024 | $324.37M |
| Total Assets restated | Q1 2024 · Dec 31, 2023 | $332.68M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2024 | −$0.21 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.13 |
| Eps Basic restated | Q1 2024 · Mar 31, 2024 | −$0.21 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.13 |
| Sga Expense restated | Q1 2024 · Mar 31, 2024 | $54.78M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $43.82M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $7.58M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $7.05M |
| Net Income restated | Q1 2024 · Mar 31, 2024 | −$17.4M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$10.81M |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$15.13M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$9.06M |
| Gross Profit restated | Q1 2024 · Mar 31, 2024 | $47.24M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $41.81M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2024 | $13.84M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $10.23M |
| Revenue | Q1 2024 · Mar 31, 2024 | $61.08M |
| Revenue | Q1 2024 · Mar 31, 2023 | $52.04M |